InnovestX Launches New DR23 on China-Hong Kong Stocks
InnovestX, the financial investment flagship of the SCBX Group,reinforces its leadership in global investment by continuing to expand opportunities through Depositary Receipts (DRs). The company today announced the launch of five new DR23 securities, following the strong market response to the initial DR23 series—HSHD23, CATL23, and another HSHD23—which delivered solid returns and sustained growth in market capitalization.
The new DR23 series offers exposure to leading companies listed on the Hong Kong and China stock exchanges, including SMIC23, China’s top semiconductor leader whose chips are used by global technology players such as Huawei, Qualcomm, and Texas Instruments; KUAISH23, representing Kuaishou, a social media giant and TikTok challenger with over 400 million daily active users; HUAHONG23, a specialty semiconductor manufacturer serving fast-growing sectors such as EVs, IoT, and clean energy; AIA23, Asia’s largest insurance group with comprehensive offerings across life, health, investment, and diversified insurance solutions; and HKEX23, the Hong Kong Stock Exchange, a global financial hub connecting China to international markets and currently trading at one of the world’s most attractive valuations.
With this expansion, InnovestX continues to empower Thai investors by providing seamless access to high-potential global assets. DRs can be traded conveniently in Thai Baht, just like local stocks, with no foreign tax obligations. All five new DR23 securities are available for trading starting 21 August 2025 via the Streaming application.
Mr. Payon Pongsawaree, Chief Investment Officer of InnovestX,China’s economy continues to face pressure from geopolitical tensions and ongoing trade disputes. However, the current trajectory reflects the government’s efforts to drive broad-based economic recovery and strengthen key sectors such as technology, finance, and digital industries. Supported by a series of stimulus measures introduced in recent months, the IMF has revised its growth forecast for China this year significantly upward to 4.8% from the previous 4%. While Chinese equities still carry certain risks, their strong growth potential combined with government policies that support critical industries make this an opportune time to gradually accumulate quality assets from both the Chinese and Hong Kong markets.
In today’s world of heightened uncertainty, investors need an All-Weather Portfolio that can adapt to every market condition—helping them navigate volatility while seizing opportunities across cycles. This is fully aligned with InnovestX’s commitment to continuously curating quality products and new opportunities for investors. The launch of the new DR23 series not only enhances portfolio diversification but also reaffirms that, whatever opportunities arise, InnovestX is ready to provide access and stand alongside Thai investors in every market environment.”
The new DR23 series comprises:
1. SMIC23 – DR of SMIC, China’s leading semiconductor manufacturer and the country’s No. 1 chipmaker, supplying major global brands such as Huawei, Qualcomm, and Texas Instruments. Backed by strong government support and rising global demand for semiconductors, SMIC is well positioned for long-term market expansion.
2. KUAISH23 – DR of Kuaishou, a major social media and e-commerce platform in China and a leading competitor to TikTok. The company leverages its proprietary Kling AI technology to reduce costs and enhance content quality, while expanding into international markets with strong backing from Tencent.
3. HUAHONG23 – DR of Huahong Semiconductor, a leading specialty chipmaker focused on serving growth sectors such as EVs, IoT, and clean energy. Unlike high-volume competitors, Huahong specializes in advanced, durable, and highly complex chips designed for critical applications.
4. AIA23 – DR of AIA Group, Asia’s largest life insurer with a comprehensive portfolio spanning life, health, and investment products. With over USD 300 billion in assets under management, AIA focuses on A-rated bonds and benefits from strong capital reserves and solid cash flow.
5. HKEX23 – DR of HKEX, the Hong Kong Stock Exchange, a premier global financial hub connecting China with the world. With a diverse business covering equities, derivatives, commodities, and ETFs, HKEX enjoys robust profitability, distributes nearly 90% of its earnings as dividends, and remains a global leader in IPO fundraising.
InnovestX’s DR23, rated AA by Fitch Ratings, opens the door to global investing by enabling Thai investors to access world-class equities as easily as trading local stocks. DR23 is priced at Fair Value, aligned with the underlying assets and adjusted by competitive exchange rates under the SCBX Group collaboration. Liquidity is further supported by a dedicated Market Maker, particularly during overlapping trading hours between the Thai and international markets, ensuring smooth transactions and market stability.
A key strength of DR23 lies in InnovestX’s experienced team specializing in DR issuance and management, supported by in-depth insights from InnovestX Research and the InnovestX Investment Products & Strategy team. Investors benefit from comprehensive analysis covering macroeconomics, fundamentals, technical factors, and investment recommendations. To enhance confidence, InnovestXalso provides access to detailed information on the underlying stocks of DR23 and a dedicated DR23 Fair Value calculator to minimize pricing discrepancies.
All of this is within reach on the InnovestX application—a trusted investment platform under SCBX, delivering Access, Advantage, and All-in-One investing across global markets.
Investors can simply enter the symbols SMIC23, KUAISH23, HUAHONG23, AIA23, or HKEX23 on the Streaming application to place buy or sell orders immediately. Whether using an InnovestXaccount or another broker, all five DR23 securities can be traded just like Thai stocks—making global investment opportunities more accessible and convenient with added confidence.
For more details, visit Facebook or Line: @InnovestX
*Terms and conditions apply.
#InnovestX #InnovestXSuperApp #AccessAdvantageAllinOne
Investors should carefully study the product features, return conditions, and associated risks before investing.
